Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab with or without laser photocoagulation for diabetic macular edema
jRCTs031180328Completed
- Sponsor
- Novartis
- Start
- Apr 2015
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised trial of ranibizumab in diabetic macular edema (DME) (2 arms), sponsored by Novartis. Primary endpoint: Visual acuity (primary). Started Apr 2015; status: completed.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on jRCTs031180328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180328.